Grant: Discovery Grants Program - Individual
University of British Columbia
$51,000.00
Towards Personalized Medicine: Molecular Imaging and Internal Radiotherapy
FY 2015-16
Summary
Recent progress in biology, chemistry and physics has open up unprecedented opportunities to advance the treatment of many diseases by employing radiopharmaceuticals in a ""personalized medicine"" paradigm. Nuclear medicine (NM) imaging techniques, such as PET and SPECT, are already well recognized for their molecular characteristics. Both techniques rely on the use of biologically active molecules, labeled with radioactive isotopes, to provide physicians with diagnostic information about the anatomy and/or physiology of patients. This not only helps to diagnose diseases, but also allows doctors to locate molecular receptor sites, study biological markers expressed by diseased cells, and monitor the presence and/or extent of specific disease processes. Additionally, in targeted internal radiotherapy (IRT), the same molecules labeled with therapeutic agents are used to deliver treatment to locations previously identified in diagnostic studies.
The effectiveness of these medical procedures is, however, highly dependent both on the accuracy of localization of radiolabeled molecules and on the accuracy of quantitative measurement of their concentrations. In particular, to optimize IRT outcomes and minimize potential damage to healthy tissues, accurate dosimetry calculations must be performed. These calculations, however, remain very challenging due to the limited accuracy of radiotracer distribution measurements in routine imaging studies. As a result, dosimetry is often not performed or only crude estimates of delivered doses used.
The main objective of the research program of my Medical Imaging Research Group (MIRG) is to use advanced physics, mathematics and computer science to develop new and improved methods for diagnostic and therapeutic nuclear medicine suitable for use both in everyday clinical practice and in medical and molecular research. The projects presented in this application utilize physics principles and build on past MIRG research to develop new techniques which should help to advance routine clinical practice to the personalized medicine era.
Program
Discovery Grants Program - Individual
Recipient
Location
British Columbia, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data
As published
Application id
194512-2012
Name nom
Celler, Anna
Department département
Radiology
Organization id
2
Institution établissement
University of British Columbia
Province en
British Columbia
Province fr
Colombie-Britannique
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2015
Competition year année de concours
2012
Award amount
51000
Program id
RGPIN
Program name en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
1505
Committee name en
Physics
Committee name fr
Physique
Area of application code
518
Area of application group en
Manufacturing processes and products
Area of application group fr
Procédés et produits industriels
Area of application en
Medical equipment and apparatus
Area of application fr
Appareils et instruments médicaux
Research subject code
3114
Research subject group en
Physics
Research subject group fr
Physique
Research subject en
Biological and Medical Physics
Research subject fr
Physique biologique et médicale
Partie
4
Nb partie
5
Application title
Towards Personalized Medicine: Molecular Imaging and Internal Radiotherapy
Keyword
NSERC
Application summary
Recent progress in biology, chemistry and physics has open up unprecedented opportunities to advance the treatment of many diseases by employing radiopharmaceuticals in a ""personalized medicine"" paradigm. Nuclear medicine (NM) imaging techniques, such as PET and SPECT, are already well recognized for their molecular characteristics. Both techniques rely on the use of biologically active molecules, labeled with radioactive isotopes, to provide physicians with diagnostic information about the anatomy and/or physiology of patients. This not only helps to diagnose diseases, but also allows doctors to locate molecular receptor sites, study biological markers expressed by diseased cells, and monitor the presence and/or extent of specific disease processes. Additionally, in targeted internal radiotherapy (IRT), the same molecules labeled with therapeutic agents are used to deliver treatment to locations previously identified in diagnostic studies.
The effectiveness of these medical procedures is, however, highly dependent both on the accuracy of localization of radiolabeled molecules and on the accuracy of quantitative measurement of their concentrations. In particular, to optimize IRT outcomes and minimize potential damage to healthy tissues, accurate dosimetry calculations must be performed. These calculations, however, remain very challenging due to the limited accuracy of radiotracer distribution measurements in routine imaging studies. As a result, dosimetry is often not performed or only crude estimates of delivered doses used.
The main objective of the research program of my Medical Imaging Research Group (MIRG) is to use advanced physics, mathematics and computer science to develop new and improved methods for diagnostic and therapeutic nuclear medicine suitable for use both in everyday clinical practice and in medical and molecular research. The projects presented in this application utilize physics principles and build on past MIRG research to develop new techniques which should help to advance routine clinical practice to the personalized medicine era.